sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
22-Jul-2014 07:23
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 826-850 out of 861.

<< < 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>

Public Release: 22-Aug-2012
As TB grows more difficult to control, vaccine candidate to prevent disease enters clinical testing
Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate. The Phase I clinical trial will assess the safety, tolerability and immunogenicity of the vaccine candidate. The study will be conducted by Johnson County Clin-Trials in Lenexa, Kansas. Tuberculosis, which kills more people than any other infectious disease except HIV, has orphaned 10 million children, and costs the global economy an estimated one billion dollars every day.

Contact: Jamie Rosen
jrosen@aeras.org
301-547-2853
Aeras

Public Release: 22-Aug-2012
Genome Research
Scientists reveal how river blindness worm thrives
Scientists at the University of Liverpool have found that the worm which causes River Blindness survives by using a bacterium to provide energy, as well as help 'trick' the body's immune system into thinking it is fighting a different kind of infection.

Contact: Kate Mizen
kate.mizen@liv.ac.uk
0044-151-794-2247
University of Liverpool

Public Release: 19-Aug-2012
American Chemical Society's 244th National Meeting & Exposition
New technology combats global pandemic of drug counterfeiting
Drug counterfeiting is so common in some developing countries that patients with serious diseases in Southeast Asia and elsewhere have been more likely to get a fake drug than one with ingredients that really treat their illness, a scientist involved in combating the problem said here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society

Public Release: 17-Aug-2012
New book tells story of 10-year-old malaria project
This year marks the tenth anniversary of the announcement of the genome sequence of the deadly human malaria parasite Plasmodium falciparum and its mosquito vector. A new book on malaria by biologist Irwin W. Sherman of the University of California, Riverside tells the story of how the Plasmodium falciparum Genome Project came into being, the people who created it, and the vast cadre of scientists attempting to realize the promise of the 10 year-old project.

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 16-Aug-2012
East meets West to bring improved sanitation and hygiene practices to Vietnam, Cambodia
East Meets West has received a US $10.9 million grant from the Bill & Melinda Gates Foundation to improve sanitation and hygiene practices among the rural poor in Vietnam and Cambodia. In these countries, open defecation and the unsafe disposal of human waste result in an estimated 17,000 deaths annually, 90 percent of which occur in children under age five and US $1.2 billion in economic losses each year.
Bill and Melinda Gates Foundation

Contact: Guillermo Meneses
guillermo.meneses@gmmb.com
202-813-4821
GMMB

Public Release: 16-Aug-2012
Journal of Biological Chemistry
Turmeric spices up virus study
Curcumin, found in the popular spice turmeric, stopped the potentially deadly Rift Valley Fever virus from multiplying in infected cells, a new study from George Mason University shows.

Contact: Michele McDonald
mmcdon15@gmu.edu
703-993-8781
George Mason University

Public Release: 16-Aug-2012
IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
The Infectious Disease Research Institute, a Seattle-based nonprofit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, announce that they have been cleared by the FDA to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
Defense Advanced Research Projects Agency

Contact: Lee Schoentrup
lee.schoentrup@idri.com
206-518-6290
Infectious Disease Research Institute

Public Release: 16-Aug-2012
Immunity
Discovery of immune cells that protect against multiple sclerosis offers hope for new treatment
Immune cells called dendritic cells, which were previously thought to contribute to the onset and development of multiple sclerosis, actually protect against the disease in a mouse model, according to a study published by Cell Press in the August issue of the journal Immunity. These new insights change our fundamental understanding of the origins of multiple sclerosis and could lead to the development of more effective treatments for the disease.

Contact: Lisa Lyons
elyons@cell.com
617-386-2121
Cell Press

Public Release: 16-Aug-2012
Lancet
World's largest tobacco use study: Tobacco control remains major challenge
An international survey of tobacco use in three billion individuals, published in the current issue of the Lancet, demonstrates an urgent need for policy change in low- and middle-income countries, according to the University at Buffalo professor who led the research.
Various

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-4605
University at Buffalo

Public Release: 16-Aug-2012
Cell
Poxviruses defeat antiviral defenses by duplicating a gene
Scientists have discovered that poxviruses, which are responsible for smallpox and other diseases, can adapt to defeat different host antiviral defenses by quickly and temporarily producing multiple copies of a gene that helps the viruses to counter host immunity.

Contact: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences

Public Release: 15-Aug-2012
Cell Host & Microbe
Duke scientists discover genetic material in blood cells that may affect malaria parasites
Researchers at Duke University Medical Center may finally have discovered why people with sickle cell disease get milder cases of malaria than individuals who have normal red blood cells. In a finding that has eluded scientists for years, Duke researchers discovered that genetic material in red blood cells may help alter parasite activity via a novel mechanism that alters parasite gene regulation.
Duke Chancellor's Pilot Project, Roche Foundation for Anemia Research, Burroughs Welcome Fund, Doris Duke Charitable Foundation

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center

Public Release: 15-Aug-2012
Alcoholism: Clinical & Experimental Research
Tracking the effects of prenatal alcohol exposure through to 9 years of age
Although studies of alcohol's effects on fetal growth have consistently demonstrated deficits that persist through infancy, the data on long-term postnatal growth from human studies have been inconsistent. A new study of the effects of heavy prenatal alcohol exposure on growth and body composition throughout childhood has found growth restrictions that persist through to nine years of age, as well as a delay in weight gain during infancy, both of which were exacerbated by iron deficiency.
NIH/National Institute on Alcohol Abuse and Alcoholism, NIH/Office of Research

Contact: R. Colin Carter, M.D.
robertcolin.carter@childrens.harvard.edu
617-355-6624
Alcoholism: Clinical & Experimental Research

Public Release: 14-Aug-2012
Lancet
Nurses as effective as doctors in treatment of HIV patients
Nurse-centered care of HIV patients can be just as safe and effective as care delivered by doctors and has a number of specific health benefits, according to a new study led by the University of East Anglia and the University of Cape Town.
Medical Research Council, Development Cooperation Ireland, Canadian International Development Agency

Contact: Simon Dunford
s.dunford@uea.ac.uk
44-160-359-2203
University of East Anglia

Public Release: 10-Aug-2012
International Journal of Tuberculosis and Lung Disease
New approach of resistant tuberculosis
Scientists of the Antwerp Institute of Tropical Medicine have breathed new life into a forgotten technique and so succeeded in detecting resistant tuberculosis in circumstances where so far this was hardly feasible. Tuberculosis bacilli that have become resistant against our major antibiotics are a serious threat to world health.
Damien Foundation

Contact: prof Bouke De Jong
bdejong@itg.be
32-324-76590
Institute of Tropical Medicine Antwerp

Public Release: 9-Aug-2012
Journal of the Pediatric Infectious Diseases Society
First antibiotic stewardship probed in the Journal of the Pediatric Infectious Diseases Society
The articles address: Impact of prospective-audit-with-feedback program and clinician attitudes toward program.

Contact: Jodie Klein
jodieklein@kleinonpoint.com
703-528-3333
Pediatric Infectious Diseases Society

Public Release: 9-Aug-2012
Wastewater key to quenching global thirst, UCI-led review finds
Parched cities and regions across the globe are using sewage effluent and other wastewater in creative ways to augment drinking water, but 4 billion people still do not have adequate supplies, and that number will rise in coming decades. Wildlife, rivers and ecosystems are also being decimated by the ceaseless quest for new water and disposal of waste. Changing human behavior and redoubling use of alternatives are critical to breaking that cycle.

Contact: Janet Wilson
janethw@uci.edu
949-824-3969
University of California - Irvine

Public Release: 7-Aug-2012
Clinical trial for rabies monoclonal antibody
A clinical trial for an anti-rabies human monoclonal antibody developed through a partnership between MassBiologics (UMass Medical School) and the Serum Institute of India is enrolling patients. The study, sponsored by the Serum Institute, will evaluate post-exposure prophylaxis following rabies exposure compared to standard treatment. Post-exposure prophylaxis for rabies that includes a monoclonal antibody should provide a more affordable, safer alternative to this world-wide public health problem, which impacts 10 million people a year.

Contact: Mark L. Shelton
mark.shelton@umassmed.edu
508-856-2000
University of Massachusetts Medical School

Public Release: 5-Aug-2012
Nature Genetics
Out of Europe
Researchers show that access to clean water might not reduce the incidence of dysentry as a country becomes more developed. As countries become more industrialized, and improve health, lifestyle and access to clean water, the numbers of infections with dysentery-causing Shigella flexneri decline. However, incidence of another form of the dysentery-causing bacterium, Shigella sonnei, increase with these improvements.
Wellcome Trust, Victorian Government

Contact: Aileen Sheehy
press.office@sanger.ac.uk
44-012-234-96928
Wellcome Trust Sanger Institute

Public Release: 2-Aug-2012
International Journal of Computational Science and Engineering
Detecting thyroid disease by computer
Researchers in India have developed an improved expert system for the diagnosis of thyroid disease. They describe details of their approach to screening medical data in a forthcoming issue of the International Journal of Computational Science and Engineering.

Contact: Nallamuthu Rajkumar
rknpsna@gmail.com
Inderscience Publishers

Public Release: 2-Aug-2012
5-year survey confirms Uruguay's world-leading tobacco control strategy is delivering results
The International Tobacco Control Policy Evaluation Project today launched a new report on the effectiveness of tobacco control policies in Uruguay. The ITC Uruguay Survey found that the country's world-leading, comprehensive tobacco control strategy has had positive effects on raising awareness of the true harms of smoking, reducing mis-perceptions about "light/mild" cigarettes, reducing exposure to secondhand smoke, and reducing the demand for tobacco products through tax increases.

Contact: Tracey Johnston
traceyj1@hotmail.com
44-077-623-10248
University of Waterloo

Public Release: 1-Aug-2012
PLOS Neglected Tropical Diseases
Global health researchers urge integrating de-worming into HIV care in Africa
An estimated 50 percent of the 2.1 million children with HIV infections in sub-Saharan African also have worm infestations. Such parasites have many health and child development repercussions, including hastening the progression of HIV. Proven interventions, including routine de-worming among children could effectively be integrated into HIV care. Global health researchers see this as a missed opportunity to treat a neglected tropical disease. School programs are not as effective in carrying out this public health intervention because they miss toddlers and pre-schoolers.
Research Resources, National Institutes of Health

Contact: Bobbi Nodell
bnodell@uw.edu
206-543-7129
University of Washington

Public Release: 1-Aug-2012
Malaria Journal
New research reveals extent of poor-quality antimalarial medicines in South American countries
Two articles recently published in Malaria Journal shed new light on the quality of antimalarial medicines circulating in countries in the Amazon Basin in South America. Researchers from the Promoting the Quality of Medicines program, a cooperative agreement between the US Agency for International Development and the US Pharmacopeial Convention, in conjunction with country partners, coordinated these studies in the context of the Amazon Malaria Initiative.
USAID, US Pharmacopeia

Contact: Theresa Laranang-Mutlu
trl@usp.org
301-816-8167
US Pharmacopeia

Public Release: 1-Aug-2012
Sleep
Global 'sleeplessness epidemic' affects an estimated 150 million in developing world
Levels of sleep problems in the developing world are approaching those seen in developed nations, linked to an increase in problems like depression and anxiety.

Contact: Anna Blackaby
a.blackaby@warwick.ac.uk
44-024-765-75910
University of Warwick

Public Release: 1-Aug-2012
American Journal of Tropical Medicine and Hygiene
New study finds strong evidence of humans surviving rabies bites without treatment
Challenging conventional wisdom that rabies infections are 100 percent fatal unless immediately treated, scientists studying remote populations in the Peruvian Amazon at risk of rabies from vampire bats found 11 percent of those tested showed protection against the disease, with only one person reporting a prior rabies vaccination. Ten percent appear to have survived exposure to the virus without any medical intervention. The findings from investigators at the CDC published by the American Journal of Tropical Medicine and Hygiene.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Public Release: 31-Jul-2012
XIX International AIDS Conference
Early treatment could mean greater earning potential for people with HIV
In a first-of-its-kind health campaign in Uganda, researchers from the University of North Carolina at Chapel Hill show that adults with HIV who had less severe infections could work more hours per week, and their children were more likely to be enrolled in school.

Contact: Thania Benios
thania_benios@unc.edu
919-962-8596
University of North Carolina at Chapel Hill

Showing releases 826-850 out of 861.

<< < 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>